A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
出版年份 2021 全文链接
标题
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-02
DOI
10.1186/s12933-021-01228-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients
- (2020) Shih-Chieh Shao et al. Cardiovascular Diabetology
- Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
- (2020) Ayako Fuchigami et al. Cardiovascular Diabetology
- Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
- (2020) Hidekazu Tanaka et al. Cardiovascular Diabetology
- Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial ( STOP‐OB )
- (2020) Toru Kitazawa et al. DIABETES OBESITY & METABOLISM
- The Effects of Canagliflozin compared to Sitagliptin on Cardiorespiratory Fitness in Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: Results of the CANA‐HF Study
- (2020) Salvatore Carbone et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pericardial fat and its influence on cardiac diastolic function
- (2020) Vera H. W. de Wit-Verheggen et al. Cardiovascular Diabetology
- SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes
- (2020) Brendon L Neuen et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
- (2019) Kyoung Jin Kim et al. Cardiovascular Diabetology
- Canagliflozin for Japanese patients with chronic heart failure and type II diabetes
- (2019) Akira Sezai et al. Cardiovascular Diabetology
- Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder
- (2019) Ming Li et al. Orphanet Journal of Rare Diseases
- Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
- (2019) Fumika Shigiyama et al. Diabetes Therapy
- Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
- (2019) Benedetta Maria Bonora et al. Cardiovascular Diabetology
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes Mellitus
- (2019) Jung-Chi Hsu et al. Scientific Reports
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- The effect of dapagliflozin treatment on epicardial adipose tissue volume
- (2018) Takao Sato et al. Cardiovascular Diabetology
- Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics
- (2018) Salvatore Carbone et al. DIABETES OBESITY & METABOLISM
- Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
- (2018) Fumitaka Soga et al. Cardiovascular Diabetology
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Value of123I-BMIPP SPECT in Patients with Nonischemic Heart Failure with Preserved Ejection Fraction
- (2017) Hidenobu Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
- (2017) Shusuke Yagi et al. Diabetology & Metabolic Syndrome
- Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
- (2017) Jing Wei Li et al. Scientific Reports
- Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
- (2017) Lars C. Gormsen et al. Journal of the American Heart Association
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy
- (2016) Eiryu Sai et al. HEART AND VESSELS
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
- (2016) Eylem Levelt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
- (2016) Fumika Shigiyama et al. Journal of Diabetes Investigation
- Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat–Fed Diabetic Mice
- (2015) Erin E. Mulvihill et al. DIABETES
- Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes
- (2015) Tushar P. Patel et al. HEART FAILURE REVIEWS
- Evaluation of Myocardial Triglyceride Accumulation Assessed on 1H-Magnetic Resonance Spectroscopy in Apparently Healthy Japanese Subjects
- (2015) Eiryu Sai et al. INTERNAL MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers
- (2015) Pál Maurovich-Horvat et al. Obesity
- Uric Acid Levels, Kidney Function, and Cardiovascular Mortality in US Adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002
- (2014) Michelle C. Odden et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study
- (2014) Takahiro Watanabe et al. Journal of Diabetes Investigation
- Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis
- (2013) Michio Shimabukuro et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiac Steatosis Associates With Visceral Obesity in Nondiabetic Obese Men
- (2013) Marit Granér et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue
- (2011) Yoichiro Hirata et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pericardial Rather Than Epicardial Fat is a Cardiometabolic Risk Marker: An MRI vs Echo Study
- (2011) Rosa Sicari et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)
- (2009) Jingzhong Ding et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample
- (2008) Guido A. Rosito et al. CIRCULATION
- Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
- (2008) Luuk J. Rijzewijk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Uric Acid and Cardiovascular Risk
- (2008) Daniel I. Feig et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now